ESTA Establishment Labs: Margin operasi

Lambang korporat lan logo Establishment Labs Inc (ESTA)

The ambitious management of Establishment Labs (ESTA) has ensured confident global development. The historical operating margin reflects current trends, where the parameter has stabilized at -6.60. Growth prospects rely on the implementation of the Mia system, FDA approval, and expansion into the US. Additional potential is created by unique patents for biocompatible surfaces, which allow the company to effectively displace traditional players in the aesthetic surgery segment.

ESTA: Margin operasi Establishment Labs Holdings Inc. 04.07.2022 - 19.11.2026

Establishment Labs - rincian analitis lan metrik utama (ESTA)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:ESTA, Establishment Labs Corp
Produk merek Establishment Labs Inc

Long-term investment success depends on the ability to distinguish market noise from actual business efficiency. Stable demand for Motiva implants provides Establishment Labs (ESTA) with a reliable cash flow, maintaining operational momentum. By analyzing the profitability of core operations, an investor can see the operating profit margin relative to total revenue. This metric excludes the impact of taxes and debt loads, exposing the quality of cost management. The growing trend confirms the high efficiency of the business model.

Pesaing Establishment Labs (ESTA)

BSX (Boston Scientific Corporation Inc.) - Margin operasi|Margin operasi Edwards Lifesciences Inc.|Margin operasi RMD|Margin dodolan operasi Insulet Corporation PODD|Rentabilitas operasi Zimmer Biomet ZBH|CooperVision - Rentabilitas operasi|ALGN - Rentabilitas operasi|GMED: Rentabilitas operasi|TMDX (TransMedics Corp) - Margin dodolan operasi|Alphatec Holdings, Inc. - Tingkat bathi operasi|AORT (Artivion Corp) - Margin operasi|Rentabilitas dodolan operasi Enovis Corp ENOV|Rentabilitas operasi Integra LifeSciences Corp (IART)|Beta Bionics Inc (BBNX) - Tingkat bathi adhedhasar bathi operasi|IRADIMED Inc. - Margin dodolan operasi|Margin operasi Embecta Corp. EMBC|Tandem Diabetes Care Inc - Margin operasi|Rentabilitas kegiatan operasi AxoGen Inc AXGN|SI-BONE (SIBN) - Rentabilitas operasi|Margin bathi operasi OFIX (Orthofix Corp)|BVS (Bioventus Inc) - Margin operasi|Margin dodolan operasi OrthoPediatrics Corp. (KIDS)|Margin operasi TMCI|SRTA - Rentabilitas dodolan operasi|Rentabilitas operasi Carlsmed Inc CARL|RXST: Rentabilitas dodolan miturut bathi operasi|CLPT: Margin dodolan operasi|stereotaxis.com - Rasio bathi operasi|NeuroStar (STIM) - Rentabilitas operasi|SGHT - Rentabilitas kegiatan operasi|Rentabilitas operasi Orchestra BioMed|Rentabilitas dodolan miturut bathi operasi ANIK (Anika Therapeutics)|Rentabilitas operasi inspiremd.com (NSPR)|Jin Medical International Ltd - Rentabilitas dodolan miturut bathi operasi|Margin operasi VANI (Vivani Medical Inc)|XTNT: Rentabilitas dodolan miturut bathi operasi|NMTC - Rentabilitas operasi|MODD: Rentabilitas operasi|MYO: Margin operasi|envoymedical.com - Tingkat bathi operasi|Margin dodolan operasi VVOS|Rentabilitas dodolan operasi enVVeno NVNO|Margin operasi SINT|TNON - Rentabilitas dodolan operasi|Rentabilitas operasi ReWalk Robotics LFWD|AMIX: Rentabilitas dodolan miturut bathi operasi|IVF - Rentabilitas operasi|Rentabilitas dodolan operasi Bone Biologics Corp|AXNX: Margin operasi|Margin dodolan operasi BIOLASE, Inc.|Margin dodolan operasi DYNT|Margin dodolan operasi Paragon 28 (FNA)|Rentabilitas operasi INVO Bio (INVO)